Navigation Links
Merck Wins Appeal of First VIOXX(R) Case to go to Trial
Date:5/30/2008

Merck Also Wins Appeals of Major Aspects of New Jersey Cases

WHITEHOUSE STATION, N.J., May 30 /PRNewswire-USNewswire/ -- Merck & Co., Inc. said today that it is gratified that a Texas appeals court overturned the August 2005 verdict of a state court jury in Brazoria County and rendered a judgment in favor of Merck in the VIOXX product liability case Ernst v. Merck. It was the first VIOXX case to go to trial after the Company voluntarily removed the medicine from the market.

Merck also said today that a New Jersey appellate division has overturned the punitive damage and consumer fraud awards in the 2006 verdict in a two-plaintiff VIOXX trial involving Thomas Cona and John McDarby.

"We are gratified that the Texas appeals court correctly found that VIOXX did not cause Mr. Ernst's death and reversed the previous decision for the plaintiff in the first VIOXX case to go to trial. In addition, the New Jersey court correctly reversed the awards of punitive damage and consumer fraud. Today's decisions overturn almost $40 million of damages and attorneys fees previously awarded to plaintiffs at trial," said Bruce Kuhlik, executive vice president and general counsel of Merck & Co., Inc. "We intend to seek further review of the portion of the award that remains standing after the New Jersey decision. We continue to believe Merck acted responsibly."

Ernst Decision

The Texas Fourteenth Court of Appeals found that VIOXX did not cause the death of Mr. Ernst, reversed the jury's verdict and rendered a judgment in favor of Merck.

Chief Justice Adele Hedges, writing for a unanimous panel, said in the ruling, "we find no evidence that Ernst suffered a thrombotic cardiovascular event, i.e., a myocardial infarction triggered by a blood clot. Accordingly, appellee failed to show that ingestion of VIOXX caused her husband's death."

The jury's original verdict on Aug. 19, 2005 included $24,450,000 in compensatory damages and $229,000
'/>"/>

SOURCE Merck
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. The African Medical and Research Foundation (AMREF) Honors Merck & Co., Inc. with Global Corporate Philanthropy Award
4. Merck & Co., Inc. Response to Todays New York Medicaid Suit
5. Mylan Vice Chairman and CEO Robert J. Coury to Ring NYSE Closing Bell(R) in Celebration of Merck Generics Acquisition
6. AHF Challenges Merck Over Steep Price of Its New AIDS Drug, Isentress
7. ImClone and Bristol-Myers Squibb Announce Joint Agreement With Merck KGaA to Co-Develop and Co-Commercialize ERBITUX(R) in Japan
8. Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3
9. The Lanier Law Firm Announces $4.85 Billion National Vioxx Settlement With Merck & Co. Inc.
10. GlaxoSmithKline Obtains Exclusive U.S. OTC Marketing Rights to MEVACOR(R) (lovastatin) from Merck & Co., Inc.
11. ICx Technologies Works With Merck & Co., Inc. to Develop Cancer Diagnostic Technology
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/21/2014)... Coral Gables, FL (PRWEB) December 21, 2014 ... of head lice, who do they call? The new answer ... Leon Blvd, Coral Gables FL 33134, their newest treatment center ... eradicate this pest quickly, conveniently and without the use of ... Grand Opening is scheduled for January 1, 2015. Like the ...
(Date:12/21/2014)... NY (PRWEB) December 21, 2014 The ... 1,400 in a consolidated litigation underway in New Jersey, ... a total of 1,375 claims involving the birth control ... Court. These lawsuits were filed by women who allege ... have led to uterine perforations and other complications they ...
(Date:12/21/2014)... Portland, OR (PRWEB) December 21, 2014 ... discussing some of the issues and systemic barriers for ... ITU World Paratriathlon Champion. Scheidies has a condition called ... over time. He describes how he adapted his athletic ... to use his success in triathlon to pioneer the ...
(Date:12/21/2014)... Virginia (PRWEB) December 21, 2014 Concept Plus, ... and engineering firm headquartered in Fairfax, VA., today announced ... of its Fast 50 list, which ranks the fastest growing ... rate from 2009 to 2013. , This is the first ... and it ranked # 20 with a 95.92% compound annual ...
(Date:12/20/2014)... New York, NY (PRWEB) December 20, 2014 ... with the healthcare sector have benefited the Massage ... Given the discretionary characteristics of industry products, the anticipated ... the five-year period has provided consumers with the means ... adults that have received a massage in a given ...
Breaking Medicine News(10 mins):Health News:All-Natural Florida Lice Removal Company Opens New Lice Treatment Salon In South Florida 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 2Health News:Mirena Lawsuits Approach 1,400 in Bergen County Litigation, Bernstein Liebhard LLP Reports 3Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 2Health News:Disability in Sports on SCI TV with Triathlon World Champ Aaron Scheidies 3Health News:Concept Plus, LLC. Named One of Washington Technology’s Fast 50 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Massage Services in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... Jan. 24 (HealthDay News) -- People with chronic obstructive pulmonary ... die from cardiovascular disease or other conditions that are not ... suggests that doctors need to be more aware of these ... is known. In recent years, the average age of ...
... Ky. (Jan. 24, 2011) - Linda J. Van Eldik, director ... been awarded a $750,000 grant to further her research into ... the Edward N. And Della L. Thome Memorial Foundation, and ... Discovery Research to be given in the U.S. in 2010. ...
... SUNDAY, Jan. 23 (HealthDay News) -- Yoga may be becoming ... People have been practicing yoga for millennia to improve their ... philosophy have kept the exercise discipline firmly within the realm ... scientific evidence is building the case that the spiritual balance ...
... Reporter , MONDAY, Jan. 24 (HealthDay News) -- The anti-estrogen ... ago may also reduce the risk of dying from lung ... Jan. 24 online edition of the journal Cancer , ... women who already had breast cancer. However, the results ...
... the Indiana University School of Medicine and the Regenstrief ... women are screened for chlamydia at a significantly higher ... rates may contribute to nationwide reporting of higher rates ... The research, which used data from more than ...
... This release is available in ... scientist Dr. Timothy Geary received a $1-million grant today ... derived from African biodiversity. Grand Challenges Canada, Canada,s ... Research and the Bill & Melinda Gates Foundation have ...
Cached Medicine News:Health News:Increasingly, Other Ailments Prove Fatal for People With COPD 2Health News:Yoga's Spiritual Balance May Boost Health 2Health News:Yoga's Spiritual Balance May Boost Health 3Health News:Breast Cancer Drug May Also Help Lung Cancer Patients 2Health News:Young minority women screened at higher rate for chlamydia than young white women 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 2Health News:McGill awarded $1-million grant to address debilitating parasitic diseases in the developing world 3
(Date:12/19/2014)... Since last month,s FBI shutdown of online drug marketplace ... online black market for illegal drugs - Evolution Marketplace ... drugs and other illegal items.  New numbers from the ... lowering the numbers of drugs and illegal items available ... But some new sites that have emerged as potentially ...
(Date:12/19/2014)... and LYON, France , ... LLY ) and Adocia (Euronext Paris: FR0011184241 ... on developing an ultra-rapid insulin, known as BioChaperone Lispro, ... 2 diabetes. BioChaperone Lispro relies on Adocia,s proprietary BioChaperone® ... Lilly and Adocia will develop BioChaperone Lispro with ...
(Date:12/17/2014)... , Dec. 17, 2014 Royal Philips ... Corporation (NASDAQ: VOLC ), a global leader in ... that they have entered into a definitive merger agreement. Pursuant ... acquire all of the issued and outstanding shares of Volcano ... price of USD 1 billion (approx. EUR 800 million), to ...
Breaking Medicine Technology:Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 2Post Silk Road - Another Online Drug Den Now Dominates the DarkNet 3Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 2Lilly and Adocia Announce Alliance to Co-Develop Ultra-Rapid Insulin Based on BioChaperone Technology 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 2Philips to acquire Volcano to expand global leadership position in image-guided therapy market 3Philips to acquire Volcano to expand global leadership position in image-guided therapy market 4Philips to acquire Volcano to expand global leadership position in image-guided therapy market 5Philips to acquire Volcano to expand global leadership position in image-guided therapy market 6Philips to acquire Volcano to expand global leadership position in image-guided therapy market 7Philips to acquire Volcano to expand global leadership position in image-guided therapy market 8
... 12, 2007,/PRNewswire-FirstCall/ -- Data analyses from the ... in the renal,anemia arena provide efficacy and ... for the treatment of,renal anemia associated with ... and not on dialysis. Three data analyses ...
... * Glivec found to dramatically reduce the risk ... (GIST) , * Patients receiving placebo in this ... regulatory submissions planned for use of Glivec as,adjuvant ... tumor , * Glivec already approved as effective ...
Cached Medicine Technology:Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 2Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 3Data Analyses Outline Efficacy and Safety of Mircera for the,Treatment of Renal Anemia Associated With Chronic Kidney Disease 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 2Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 3Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 4Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 5Positive Results Prompt US National Cancer Institute to Make Glivec,Available to Patients in Post-Surgical GIST Study 6
... closed system for performing fast, clean, safe ... system is microprocessor controlled to automatically spin ... one minute. At the end of the ... across the viewing area for microscopic analysis.,The ...
... establish temporary internal drainage from the ureteropelvic ... Non-radiopaque ink bands serve as a visual ... where the coil(s) will form as he/she ... packages. Intended for one-time use. CAUTION: Periodic ...
... Used for temporary ... ureteropelvic junction to the ... Supplied sterile in peel-open ... use. CAUTION: Periodic evaluation ...
... temporary internal drainage from the ... Supplied sterile in peel-open packages. ... Periodic evaluation is advised; polyurethane, ... not remain indwelling more than ...
Medicine Products: